Huang Guanghua, Liu Lei, Wang Luyi, Wang Zhile, Wang Zhaojian, Li Shanqing
Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
PeerJ. 2022 Feb 9;10:e12936. doi: 10.7717/peerj.12936. eCollection 2022.
No postoperative cardiopulmonary morbidity models have been developed or validated in Chinese patients with lung resection. This study aims to externally validate five predictive models, including Eurolung models, the Brunelli model and the Age-adjusted Charlson Comorbidity Index, in a Chinese population.
Patients with lung cancer who underwent anatomic lung resection between 2018/09/01 and 2019/08/31 in our center were involved. Model discrimination was assessed by the area under the receiver operating characteristic curve. Model calibration was evaluated by the Hosmer-Lemeshow test. Calibration curves were plotted. Specificity, sensitivity, negative predictive value, positive predictive value and accuracy were calculated. Model updating was achieved by re-estimating the intercept and/or the slope of the linear predictor and re-estimating all coefficients.
Among 1085 patients, 91 patients had postoperative cardiopulmonary complications defined by the European Society of Thoracic Surgeons. For original models, only parsimonious Eurolung1 had acceptable discrimination (area under the receiver operating characteristic curve = 0.688, 95% confidence interval 0.630-0.745) and calibration ( = 0.23 > 0.05) abilities simultaneously. Its sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 0.700, 0.649, 0.153, 0.960 and 0.653, respectively. In the secondary analysis, increased pleural effusion ( = 94), which was nonchylous and nonpurulent, was labeled as a kind of postoperative complication. The area under the receiver operating characteristic curve of the models increased slightly, but all models were miscalibrated. The original Eurolung1 model had the highest discrimination ability but poor calibration, and thus it was updated by three methods. After model updating, new models showed good calibration and small improvements in discrimination. The discrimination ability was still merely acceptable.
Overall, none of the models performed well on postoperative cardiopulmonary morbidity prediction in this Chinese population. The original parsimonious Eurolung1 and the updated Eurolung1 were the best-performing models on morbidity prediction, but their discrimination ability only achieved an acceptable level. A multicenter study with more relevant variables and sophisticated statistical methods is warranted to develop new models among Chinese patients in the future.
尚未针对中国肺切除患者开发或验证术后心肺并发症模型。本研究旨在在中国人群中对外验证包括欧洲肺部模型、布鲁内利模型和年龄调整查尔森合并症指数在内的五种预测模型。
纳入2018年9月1日至2019年8月31日在本中心接受解剖性肺切除的肺癌患者。通过受试者工作特征曲线下面积评估模型的区分度。通过Hosmer-Lemeshow检验评估模型的校准情况。绘制校准曲线。计算特异性、敏感性、阴性预测值、阳性预测值和准确性。通过重新估计线性预测因子的截距和/或斜率以及重新估计所有系数来实现模型更新。
1085例患者中,91例发生了欧洲胸外科医师协会定义的术后心肺并发症。对于原始模型,只有简化的欧洲肺部模型1同时具有可接受的区分度(受试者工作特征曲线下面积=0.688,95%置信区间0.630-0.745)和校准能力(=0.23>0.05)。其敏感性、特异性、阳性预测值、阴性预测值和准确性分别为0.700、0.649、0.153、0.960和0.653。在二次分析中,将增加的非乳糜性和非脓性胸腔积液(=94)标记为一种术后并发症。模型的受试者工作特征曲线下面积略有增加,但所有模型校准均不佳。原始的欧洲肺部模型1区分能力最高但校准较差,因此通过三种方法对其进行更新。模型更新后,新模型校准良好,区分度有小幅改善。区分能力仍仅为可接受水平。
总体而言,在该中国人群中没有一个模型在术后心肺并发症预测方面表现良好。原始的简化欧洲肺部模型1和更新后的欧洲肺部模型1在并发症预测方面是表现最佳的模型,但其区分能力仅达到可接受水平。未来有必要开展一项纳入更多相关变量和采用更复杂统计方法的多中心研究,以在中国患者中开发新的模型。